Protein Information

Drug Information

Drug Name Strength Dosage Form/Route Company Marketing Status Approval year
FORTEO250 MCG/MLSOLUTION; SUBCUTANEOUS(20MG/VIAL); INJECTABLE; SUBCUTANEOUS(20MG/ML; 40MG/ML)ELI LILLY CANADA INCPrescription2004
FORTEO250 MCG/MLSOLUTION; SUBCUTANEOUS(20MG/VIAL); INJECTABLE; SUBCUTANEOUS(20MG/ML; 40MG/ML)ELI LILLY CANADA INCPrescription2004
FORTEO250 MCG/MLSOLUTION; SUBCUTANEOUS(20MG/VIAL); INJECTABLE; SUBCUTANEOUS(20MG/ML; 40MG/ML)ELI LILLY CANADA INCPrescription2004